Actively Recruiting
Deciphering Preserved Autonomic Function After Multiple Sclerosis
Led by Mayo Clinic · Updated on 2026-03-05
13
Participants Needed
1
Research Sites
67 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study looks to characterize gradients of dysfunction in the autonomic nervous system in patients with clinically diagnosed multiple sclerosis. The autonomic nervous system plays key roles in regulation of blood pressure, skin blood flow, and bladder health- all issues that individuals with multiple sclerosis typically suffer. Focusing on blood pressure regulation, the most precise metric with broad clinical applicability, the investigators will perform laboratory-based tests to probe the body's ability to generate autonomic responses. For both individuals with multiple sclerosis and uninjured controls, laboratory-based experiments will utilize multiple parallel recordings to identify how the autonomic nervous system is able to inhibit and activate signals. The investigators anticipate that those with autonomic dysfunction with multiple sclerosis will exhibit abnormalities in these precise metrics. The investigators will look to see if any substantial connections exist between different degrees of preserved autonomic function and secondary autonomic complications from multiple sclerosis. In accomplishing this, the investigators hope to give scientists important insights to how the autonomic nervous system works after multiple sclerosis and give physicians better tools to manage these secondary autonomic complications.
CONDITIONS
Official Title
Deciphering Preserved Autonomic Function After Multiple Sclerosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 to 50 years old
- Clinically confirmed diagnosis of multiple sclerosis or uninjured control
You will not qualify if you...
- Symptoms of cardiovascular, respiratory, peripheral neurological, or autonomic diseases, including diabetes mellitus requiring treatment
- Women who are pregnant or lactating
- Body mass index (BMI) equal to or greater than 35 kg/m2
- Taking medications that may have adverse interactions with phenylephrine
- Any illness or condition that may affect ability to comply with the study, patient safety, or study results interpretation in the judgment of the investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55902
Actively Recruiting
Research Team
Z
Zachary Pohlkamp
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here